Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
- 1 November 1998
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 4 (11), 1302-1307
- https://doi.org/10.1038/3293
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- Decay characteristics of HIV-1-infected compartments during combination therapyNature, 1997
- Anti-viral Drug Treatment: Dynamics of Resistance in Free Virus and Infected Cell PopulationsJournal of Theoretical Biology, 1997
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996
- Treatment with Lamivudine, Zidovudine, or Both in HIV-Positive Patients with 200 to 500 CD4+ Cells per Cubic MillimeterThe New England Journal of Medicine, 1995
- Rapid and Precise Quantification of HIV-1 RNA in Plasma Using a Branched DNA Signal Amplification AssayJAIDS Journal of Acquired Immune Deficiency Syndromes, 1995
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995
- Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.Proceedings of the National Academy of Sciences of the United States of America, 1994
- A spring-loaded mechanism for the conformational change of influenza hemagglutininCell, 1993
- A General Model for the Transmembrane Proteins of HIV and Other RetrovirusesAIDS Research and Human Retroviruses, 1989